539 related articles for article (PubMed ID: 28849159)
41. Upregulation of Transient Receptor Potential Vanilloid Type-1 Channel Activity and Ca2+ Influx Dysfunction in Human Pterygial Cells.
Garreis F; Schröder A; Reinach PS; Zoll S; Khajavi N; Dhandapani P; Lucius A; Pleyer U; Paulsen F; Mergler S
Invest Ophthalmol Vis Sci; 2016 May; 57(6):2564-77. PubMed ID: 27163769
[TBL] [Abstract][Full Text] [Related]
42. Expression and distribution of three transient receptor potential vanilloid(TRPV) channel proteins in human odontoblast-like cells.
Wen W; Que K; Zang C; Wen J; Sun G; Zhao Z; Li Y
J Mol Histol; 2017 Dec; 48(5-6):367-377. PubMed ID: 28905239
[TBL] [Abstract][Full Text] [Related]
43. The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain.
Malek N; Kostrzewa M; Makuch W; Pajak A; Kucharczyk M; Piscitelli F; Przewlocka B; Di Marzo V; Starowicz K
Pharmacol Res; 2016 Sep; 111():251-263. PubMed ID: 27326920
[TBL] [Abstract][Full Text] [Related]
44. Cannabinoid receptor activation induces apoptosis through tumor necrosis factor alpha-mediated ceramide de novo synthesis in colon cancer cells.
Cianchi F; Papucci L; Schiavone N; Lulli M; Magnelli L; Vinci MC; Messerini L; Manera C; Ronconi E; Romagnani P; Donnini M; Perigli G; Trallori G; Tanganelli E; Capaccioli S; Masini E
Clin Cancer Res; 2008 Dec; 14(23):7691-700. PubMed ID: 19047095
[TBL] [Abstract][Full Text] [Related]
45. Expression of stem cell factor in pterygium.
Nakagami T; Watanabe I; Murakami A; Okisaka S; Ebihara N
Jpn J Ophthalmol; 2000; 44(3):193-7. PubMed ID: 10913635
[TBL] [Abstract][Full Text] [Related]
46. Pharmacological effects of cannabidiol by transient receptor potential channels.
Etemad L; Karimi G; Alavi MS; Roohbakhsh A
Life Sci; 2022 Jul; 300():120582. PubMed ID: 35483477
[TBL] [Abstract][Full Text] [Related]
47. The expression of receptors for endocannabinoids in human and rodent skeletal muscle.
Cavuoto P; McAinch AJ; Hatzinikolas G; Janovská A; Game P; Wittert GA
Biochem Biophys Res Commun; 2007 Dec; 364(1):105-10. PubMed ID: 17935697
[TBL] [Abstract][Full Text] [Related]
48. Immunohistochemical profile of VEGF, TGF-β and PGE₂ in human pterygium and normal conjunctiva: experimental study and review of the literature.
Bianchi E; Scarinci F; Grande C; Plateroti R; Plateroti P; Plateroti AM; Fumagalli L; Capozzi P; Feher J; Artico M
Int J Immunopathol Pharmacol; 2012; 25(3):607-15. PubMed ID: 23058011
[TBL] [Abstract][Full Text] [Related]
49. Effects of Cocaine Self-Administration and Its Extinction on the Rat Brain Cannabinoid CB1 and CB2 Receptors.
Bystrowska B; Frankowska M; Smaga I; Pomierny-Chamioło L; Filip M
Neurotox Res; 2018 Oct; 34(3):547-558. PubMed ID: 29754307
[TBL] [Abstract][Full Text] [Related]
50. Immunolocalisation of E-cadherin and beta-catenin in human pterygium.
Kase S; Osaki M; Sato I; Takahashi S; Nakanishi K; Yoshida K; Ito H; Ohno S
Br J Ophthalmol; 2007 Sep; 91(9):1209-12. PubMed ID: 17360734
[TBL] [Abstract][Full Text] [Related]
51. Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: growth inhibition by receptor activation.
Gustafsson K; Wang X; Severa D; Eriksson M; Kimby E; Merup M; Christensson B; Flygare J; Sander B
Int J Cancer; 2008 Sep; 123(5):1025-33. PubMed ID: 18546271
[TBL] [Abstract][Full Text] [Related]
52. [The abnormal expression of epidermal growth factor receptor family in pterygium].
Liu Z; Xie Y; Zhang M; Pflugfelder SC
Zhonghua Yan Ke Za Zhi; 2000 Sep; 36(5):372-4, 25. PubMed ID: 11853633
[TBL] [Abstract][Full Text] [Related]
53. Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells.
Jean-Gilles L; Braitch M; Latif ML; Aram J; Fahey AJ; Edwards LJ; Robins RA; Tanasescu R; Tighe PJ; Gran B; Showe LC; Alexander SP; Chapman V; Kendall DA; Constantinescu CS
Acta Physiol (Oxf); 2015 May; 214(1):63-74. PubMed ID: 25704169
[TBL] [Abstract][Full Text] [Related]
54. UVB-mediated induction of interleukin-6 and -8 in pterygia and cultured human pterygium epithelial cells.
Di Girolamo N; Kumar RK; Coroneo MT; Wakefield D
Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3430-7. PubMed ID: 12407153
[TBL] [Abstract][Full Text] [Related]
55. Cannabinoid-mediated elevation of intracellular calcium: a structure-activity relationship.
Rao GK; Kaminski NE
J Pharmacol Exp Ther; 2006 May; 317(2):820-9. PubMed ID: 16436496
[TBL] [Abstract][Full Text] [Related]
56. The endovanilloid/endocannabinoid system in human osteoclasts: possible involvement in bone formation and resorption.
Rossi F; Siniscalco D; Luongo L; De Petrocellis L; Bellini G; Petrosino S; Torella M; Santoro C; Nobili B; Perrotta S; Di Marzo V; Maione S
Bone; 2009 Mar; 44(3):476-84. PubMed ID: 19059369
[TBL] [Abstract][Full Text] [Related]
57. Opposite regulation of cannabinoid CB1 and CB2 receptors in the prefrontal cortex of rats treated with cocaine during adolescence.
García-Cabrerizo R; García-Fuster MJ
Neurosci Lett; 2016 Feb; 615():60-5. PubMed ID: 26797579
[TBL] [Abstract][Full Text] [Related]
58. Distribution of vimentin-expressing cells in pterygium: an immunocytochemical study of impression cytology specimens.
Chen YT; Tseng SH; Tsai YY; Huang FC; Tseng SY
Cornea; 2009 Jun; 28(5):547-52. PubMed ID: 19421041
[TBL] [Abstract][Full Text] [Related]
59. DNA damage in human pterygium: one-shot multiple targets.
Cimpean AM; Sava MP; Raica M
Mol Vis; 2013; 19():348-56. PubMed ID: 23401662
[TBL] [Abstract][Full Text] [Related]
60. Expression of MMPs and TIMPs in human pterygia and cultured pterygium epithelial cells.
Di Girolamo N; McCluskey P; Lloyd A; Coroneo MT; Wakefield D
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):671-9. PubMed ID: 10711680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
